Evaluation of Belatacept as First-Line Immunosuppression in DeNovo Liver Transplant Recipients: Long Term Extension (LTE)
|Effective start/end date
|8/10/07 → 12/31/15
- BRISTOL-MYERS SQUIBB COMPANY
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.